Molly Stevens is Professor of Biomedical Materials and Regenerative Medicine and the Research Director for Biomedical Material Sciences in the Department of Materials, Department of Bioengineering and the Institute of Biomedical Engineering at Imperial College London.
She joined Imperial in 2004 after a Postdoctoral training in the laboratory of Professor Robert Langer at MIT. Prior to this she graduated from Bath University with a First Class Honours degree in Pharmaceutical Sciences and was then awarded a PhD in biophysical investigations of specific biomolecular interactions and single biomolecule mechanics from the Laboratory of Biophysics and Surface Analysis at the University of Nottingham (2000).
In 2010 she was recognized by The Times as one of the top ten scientists under the age of 40. She has also recently been recognized by the TR100 as one of the top innovators under the age of 35 who are transforming technology - and the world with their work. Stevens has received the Polymer International-IUPAC award, the Rosenhain medal and the Norman Heatley Prize from the Royal Society of Chemistry, the Jean Leray Award from the European Society for Biomaterials, the Conference Science Medal from the Royal Pharmaceutical Society, the Philip Leverhulme Prize, the Ronald Belcher Memorial Lecture Award from the Royal Society of Chemistry, the Janssen Prize, the UpJohn Prize, the RSC Norman Heatley Prize, the IOM3 Rosenhain Medal and Prize, and the Griffith Prize and medal. In 2013 she was elected Fellow of the Royal Academy of Engineering.
In the field of nanotechnology, Stevens is exploiting specific biomolecular recognition and self-assembly mechanisms to create new dynamic nano-materials, biosensors and drug delivery systems. Recent efforts in peptide-functionalized nanoparticles for enzyme biosensing have a host of applications across diseases ranging from cancer to global health applications.